A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/hep4.1305
PubMed Identifier: 30859149
Publication URI: http://europepmc.org/abstract/MED/30859149
Type: Journal Article/Review
Volume: 3
Parent Publication: Hepatology communications
Issue: 3
ISSN: 2471-254X